Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Replimune Group Inc (REPL)

Replimune Group Inc (REPL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Replimune Group Inc 500 Unicorn Park Drive Suite 303 WOBURN MA 01801 USA

www.replimune.com Employees: 331 P: 781-222-9600

Description:

Replimune Group, Inc. is a clinical-stage biotechnology company. It discovers, develops and commercializes oncolytic immunotherapy for the treatment of cancer diseases. The company's product pipeline consists of RP1, RP2 & RP3 which are in clinical stage. Replimune Group, Inc. is based in MA, United States.

Key Statistics

Overview:

Market Capitalization, $K 854,528
Enterprise Value, $K 824,878
Shares Outstanding, K 68,417
Annual Sales, $ 0 K
Annual Net Income, $ -215,790 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -53,060 K
EBIT, $ -231,580 K
EBITDA, $ -241,250 K
60-Month Beta 1.26
% of Insider Shareholders 8.80%
% of Institutional Shareholders 92.53%
Float, K 62,396
% Float 91.20%
Short Volume Ratio 0.61

Growth:

1-Year Return 67.43%
3-Year Return -56.65%
5-Year Return -19.21%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -143.61%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.68 on 11/12/24
Next Earnings Date 02/13/25
Earnings Per Share ttm -3.05
EPS Growth vs. Prev Qtr 12.82%
EPS Growth vs. Prev Year 24.44%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

REPL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -53.12%
Return-on-Assets % -41.49%
Profit Margin % 0.00%
Debt/Equity 0.12
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.15
Book Value/Share 5.58
Interest Coverage -31.34
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar